Tweets
A new finding - antimalarials improve safety w bDMARDs & #JAKi and reduce CV events and improve drug survival #Bestinclass. POS0242 @RheumNow @eular_org #EULAR2022 Neat. Safe, inexpensive and monitor eyes 👀 https://t.co/Ea4VA9vqwe
Janet Pope @Janetbirdope ( View Tweet )
4 years 1 month ago
Large 5 country cohort study - No increased risk of hematologic malignancies (lymphoid or myeloid) in PsA pts treated with TNFi.
In PsA overall compared to general population - moderately increased underlying risk of hematologic malignancies.
@RheumNow #EULAR2022 ABST#OP0257 https://t.co/P846RupitR
Robert B Chao, MD @doctorRBC ( View Tweet )
4 years 1 month ago
#OP0783 #EULAR2022 A study in Spain (N=72) of #Sjogren pts showed Pathologic US of salivary glands were associated with Ro52+, raised IgG, early menopause & lack Mediterranean diet. Smoking was protective but wide Confidence Interval. I wont promote smoking though @RheumNow https://t.co/kn4X4oFGzK
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
4 years 1 month ago
Female PsA patients on TNFi have reduced treatment effectiveness, LDA (vs males). #EULAR2022 POS0077 @RheumNow https://t.co/EwDwxUarNb https://t.co/W5xgQlrnlF
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 1 month ago
Hilarious debate #EULAR2022 between Christian Dejaco and Robert Landewe on whether telemedicine is the future of rheumatology. In amongst the trash talking, here are some highlights @RheumNow
David Liew @drdavidliew ( View Tweet )
4 years 1 month ago
#ClinicalPearl. Why do doctors prescribe #JAKi in RA? Efficacy, fast onset, X-ray inhibition, can work as monotherapy, remission - in order of diminishing frequency BUT I will add access and oral (convenience). POS0680 @RheumNow @eular_org #EULAR2022 https://t.co/XHtNqguqvh
Janet Pope @Janetbirdope ( View Tweet )
4 years 1 month ago
#EULAR2022 Telemedicine: PROs
💻Triage, reduce wait time, direct other specialty referral
💻High agreement w F2F evaluation (79-97%)
💻Saves resources, react quickly to minor flare
💻Better adherence
@RheumNow
Eric Dein @ericdeinmd ( View Tweet )
4 years 1 month ago
BTKi are they effective in #rheumatology? Seem to work in preclinical models of inflammation but so far clinical results seem disappointing #POS0397 @RheumNow @eular_org #EULAR2022 https://t.co/2NjcMnU1d6
Janet Pope @Janetbirdope ( View Tweet )
4 years 1 month ago
#EULAR2022
R Landewe: Anti-Telemedicine
🩺Rheumatology about long-term relationship & communication
🩺"Telemedicine impoverishes visit" by only exchanging information
@Rheumnow
Eric Dein @ericdeinmd ( View Tweet )
4 years 1 month ago
#POS0752 #EULAR2022 Is there difference btw childhood- vs adult-onset #lupus?A cohort study of claims database >10,000 pts showed:
Children had higher activity & more likely to receive immunosuppressant
Some activities persisted
Useful to bear in transition clinic @RheumNow https://t.co/KVHZUgAOlV
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
4 years 1 month ago
Inflammation (ESR >20 and cardiovascular risk scores) in AxSpA pts associated with incident hypertension.
csDMARD may be associated with HTN
NSAID and biologics not associated with incident HTN
@RheumNow #EULAR2022 ABST#POS0154 https://t.co/5pYjXrpCec
Robert B Chao, MD @doctorRBC ( View Tweet )
4 years 1 month ago
#PEARLS by EULAR President Prof Iagnocco:
1. Enthesitis can be present in 25% of #SLE patients
2. Erosions can be common and independent of ACPA/RF status
3. Active myositis is indistinguishable from IIM
4. Don't forget pain osteonecrosis/osteomyelitis #EULAR2022 @rheumnow https://t.co/8uWCw9rEve
TheDaoIndex @KDAO2011 ( View Tweet )
4 years 1 month ago
